Du J - Search Results

1

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China.

Gao W, Jian Y, Du J, Li X, Zhou H, Zhang Z, Yang G, Wang G, Tian Y, Li Y, Wu Y, Fu W, Li J, Chen W. Gao W, et al. Among authors: du j. Cancer Med. 2020 Nov;9(21):7819-7829. doi: 10.1002/cam4.3254. Epub 2020 Sep 2. Cancer Med. 2020. PMID: 32881351 Free PMC article.

2

[Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].

DU J, Yuan ZG, Zhang CY, Fu WJ, Jiang H, Chen BA, Hou J. DU J, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Oct;30(10):649-53. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19954656 Chinese.

3

Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.

Du J, Yuan Z, Zhang C, Fu W, Jiang H, Chen B, Hou J. Du J, et al. Leuk Res. 2010 Nov;34(11):1453-8. doi: 10.1016/j.leukres.2010.01.011. Epub 2010 Jan 31. Leuk Res. 2010. PMID: 20122728

4

Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.

Du J, Huo J, Shi J, Yuan Z, Zhang C, Fu W, Jiang H, Yi Q, Hou J. Du J, et al. Haematologica. 2011 May;96(5):729-37. doi: 10.3324/haematol.2010.030577. Epub 2011 Jan 12. Haematologica. 2011. PMID: 21228035 Free PMC article.

5

Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo.

Yang L, Du J, Hou J, Jiang H, Zou J. Yang L, et al. Among authors: du j. BMC Cancer. 2011 Jun 21;11:261. doi: 10.1186/1471-2407-11-261. BMC Cancer. 2011. PMID: 21693026 Free PMC article.

6

Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6.

Qu X, Du J, Zhang C, Fu W, Xi H, Zou J, Hou J. Qu X, et al. Among authors: du j. PLoS One. 2012;7(2):e32215. doi: 10.1371/journal.pone.0032215. Epub 2012 Feb 22. PLoS One. 2012. PMID: 22384180 Free PMC article.

7

[The efficacy and safety analysis of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma].

Lu J, Hou J, Zhang CY, Yuan ZG, Lan HF, Zhou F, Fan JL, Zhou LL, Du J, Jiang H, Jin LN, Zeng TM, Fu WJ. Lu J, et al. Among authors: du j. Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):309-12. doi: 10.3760/cma.j.issn.0253-2727.2013.04.013. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23668202 Chinese.

8

[Busulfan, cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma].

Zhang CY, Fu WJ, Xi H, Zhou LL, Jiang H, Du J, Fan JL, Li R, Jin LN, Zeng TM, Hou J. Zhang CY, et al. Among authors: du j. Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):313-6. doi: 10.3760/cma.j.issn.0253-2727.2013.04.014. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23668203 Chinese.

9

Depression in older patients with advanced colorectal cancer is closely connected with immunosuppressive acidic protein.

Li R, Yang J, Yang J, Fu W, Jiang H, Du J, Zhang C, Xi H, Hou J. Li R, et al. Among authors: du j. Metab Brain Dis. 2014 Mar;29(1):87-92. doi: 10.1007/s11011-013-9429-8. Epub 2013 Aug 22. Metab Brain Dis. 2014. PMID: 23975537

10

[The clinical characteristics and prognostic analysis of 147 cases of diffuse large B-cell lymphoma].

Zhao Q, Fu WJ, Zhang CY, Du J, Xi H, Hou J. Zhao Q, et al. Among authors: du j. Zhonghua Xue Ye Xue Za Zhi. 2013 Sep;34(9):737-40. doi: 10.3760/cma.j.issn.0253-2727.2013.09.001. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24103868 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,714 results

Search Page

Filters